REDWOOD CITY, CA, United States

Proteus Biomedical, Inc.

www.proteusbiomed.com
REDWOOD CITY, CA, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Proteus Biomedical, Inc. | Date: 2017-04-20

A system for tracking a product from origin to destination is disclosed. The system includes a probe that comprises two plates, a power source and a processor. The power source is controlled by the processor to produce an oscillating output at the plates. Using the oscillating voltage, the probe interrogates a device through capacitive coupling. The device includes a control unit, a memory unit, and first and second materials physically associated with the device for communication using capacitive coupling. Information associated with the device is transferred from the device to the probe through capacitive coupling between the first and second materials and the first and second plates, respectively.


Patent
Proteus Biomedical, Inc. | Date: 2017-04-19

A pharmaceutical product including a housing that defines a cavity, wherein the cavity stores a pharmaceutical material, and wherein the housing comprises a material configured to dissolve based on contact with a fluid, an ingestible device to encode information in a current signature, wherein the ingestible device is positioned within the housing, and a protective material that encompasses the ingestible device. The ingestible device may be attached to a flexible component, wherein the flexible component is configured to releasably secure the ingestible device within the housing.


Patent
Proteus Biomedical, Inc. | Date: 2017-08-16

Receivers (100, 700, 800, 900, 1000, 1520, 15105), which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.


Patent
Proteus Biomedical, Inc. | Date: 2016-05-05

A loose wearable receiver system is disclosed. A loose wearable receiver system is a body-associated personal communicator capable of detecting, monitoring, analyzing, and/or transmitting information about a wearer. The loose wearable system may be operable to detect an electrical current signature from an ingestible device indicator system. The loose wearable system may store and/or access data on a remote system. The loose wearable system may comprise a wearable component configured to be removably worn, such as on a limb. The loose wearable system comprises a compartment and optionally a battery-powered electronics module configured to be removably attached to the compartment or a charging station for charging a battery within the wearable system.


Patent
Proteus Biomedical, Inc. | Date: 2016-06-23

Systems, methods, and apparatuses are presented for resolving any interference, noise, and/or collisions caused by two or more ingestible event markers (IEMs) transmitting simultaneously or concurrently. Methods include techniques from the perspective of the IEM for randomly varying signal transmission characteristics in order to avoid collisions with other concurrently transmitting IEMs. Methods also include techniques from the perspective of a receiver for receiving multiple transmission signals from multiple IEMs and for resolving any interference or signal collisions.


Patent
Proteus Biomedical, Inc. | Date: 2016-02-23

Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.


Patent
Proteus Biomedical, Inc. | Date: 2016-07-21

An ingestible compositions includes a first polymer layer, an adhesive layer associated with the first polymer layer, where the adhesive layer includes an adhesive material and is configured to releasably adhere to the first polymer layer, an alginate layer adhered to the adhesive layer, and a second polymer layer associated with the alginate layer and configured to releasably adhere to the alginate layer. Aspects further include methods of making and using the compositions.


Patent
Proteus Biomedical, Inc. | Date: 2015-01-21

Edible adhesives and ingestible compositions that include the same are provided. Aspects further include methods of making and using the compositions.


A method may comprise receiving and sampling a signal. The signal may encode a data packet. A slice may be generated and stored comprising a pair of values for each of a selected number of samples of the signal representing a correlation of the signal to reference functions in the receiver. The presence of the data packet may then be detected and the detected packet decoded from the stored slices. The generating and storing slices may be carried out as the received signal is sampled. The sampled values of the signal may be discarded as the slices are generated and stored. The slice representation of the signal can be manipulated to generate filters with flexible bandwidth and center frequency.


Patent
Proteus Biomedical, Inc. | Date: 2016-09-07

System, method, and article to prompt behavior change are provided. Various aspects of the system include health promotion data generated and / or communicated from / to a device; a methodology module associated with software / processor to identify at least one behavior change methodology associated with the health promotion data; and an instruction module associated with a software / processor to initiate the identified at least one behavior change methodology.

Loading Proteus Biomedical, Inc. collaborators
Loading Proteus Biomedical, Inc. collaborators